AELIN THERAPEUTICS

BiotechnologySeries ALeuven, Belgiumaelintx.com

Latest round

Series A

Last raised

Dec 2017

Total raised

$32M

Investors

5

About AELIN THERAPEUTICS

Based in Belgium, and founded in 2017 by co-founders Frederic Rousseau, and Joost Schymkowitz, Aelin Therapeutics operates as a biotherapeutics company that specializes in drug discovery through its Pept-in technology platform. In June 2023, AELIN THERAPEUTICS filed for chapter 11 bankruptcy protection. Aelin's core offering is the Pept-in technology platform designed to knock down the function of critical oncoproteins and induce tumor cell death, providing a complementary strategy to existing cancer treatments. The platform interacts with intracellular targets in mammals, bacteria, and viruses, thus broadening the scope of potential therapeutic solutions.

Who invested in AELIN THERAPEUTICS

5 investors across 1 round

See all investors in AELIN THERAPEUTICS

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 11, 2017

    Amount

    $32M

    Investors

    Locked

Questions about AELIN THERAPEUTICS

Who invested in AELIN THERAPEUTICS?

AELIN THERAPEUTICS has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has AELIN THERAPEUTICS raised?

AELIN THERAPEUTICS has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did AELIN THERAPEUTICS last raise money?

AELIN THERAPEUTICS's most recent round on record is a Series A, in Dec 2017.

What does AELIN THERAPEUTICS do?

Based in Belgium, and founded in 2017 by co-founders Frederic Rousseau, and Joost Schymkowitz, Aelin Therapeutics operates as a biotherapeutics company that specializes in drug discovery through its Pept-in technology platform.

Where is AELIN THERAPEUTICS headquartered?

AELIN THERAPEUTICS is headquartered in Leuven, Belgium.

Which VCs invest in companies like AELIN THERAPEUTICS?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at AELIN THERAPEUTICS's stage. Their profiles are linked below.

Raising like AELIN THERAPEUTICS? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.